Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ivan O. Rosas, M.D.
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brompton
Brisbane, Queensland, Australia
- Royal Prince Alfred Hospital
Camperdown, Sydney, Australia
- Melbourne Alfred Hospital
Melbourne, Victoria, Australia
- the Prince Charles Hospital
Camperdown, Australia
- University of Calgary Cummings School of Medicine
Calgary, Alberta, Canada
- St. Paul'S Hospital - Providence Health Care
Vancouver, British Columbia, Canada
- St. Joseph'S Healthcare
Hamilton, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- North Bristol Nhs Trust Headquarters, Southmead Hospital
Bristol, United Kingdom
- Papworth Hospital Nhs Foundation Trust
Cambridge, United Kingdom
- Royal Devon and Exeter Nhs Foundation
Exeter, United Kingdom
- Leeds Teaching Hospitals Nhs Trust
Leeds, United Kingdom
- University Hospitals of Leicester Nhs Foundation Trust
Leicester, United Kingdom
- Aintree University Hospitals Nhs Foundation Trust
Liverpool, United Kingdom
- Royal Brompton and Harefield Nhs Foundation Trust
London, United Kingdom
- Manchester University Nhs Foundation Trust (south) Wythenshawe Hospita
Manchester, United Kingdom
- Newcastle Upon Tyne Hospitals Nhs Foundation Trust
Newcastle upon Tyne, United Kingdom
- Norfolk and Norwich University Hospitals Nhs Foundation Trust
Norwich, United Kingdom
- Oxford University Hospitals Nhs Foundation Trust
Oxford, United Kingdom
- University Hospital Southampton Nhs Foundation Trust
Southhampton, United Kingdom
- University of Alabama Site at Birmingham
Birmingham, Alabama, United States
- University of California San Francisco
San Francisco, California, United States
- National Jewish Health
Denver, Colorado, United States
- University of Miami
Miami, Florida, United States
- Tulane Medical Center
New Orleans, Louisiana, United States
- John Hopkins Medicine
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Weill Cornell Medicine
New York, New York, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Utah Health Care
Salt Lake City, Utah, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Apr 2017
- Primary completion
- 7 Apr 2021
- Completion
- 7 Apr 2021
- Last update posted
- 16 Aug 2022
- Registered enrollment
- 123
- Registry id
- NCT02808871
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.